Screener
Gilead Sciences GILD Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Gilead Sciences’s reported figures.
The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000882095-26-000024
FAQ
- What is Gilead Sciences's invested capital?
- Gilead Sciences (GILD) reported invested capital of $38.06B in Q1 2026.
- How has Gilead Sciences's invested capital changed year-over-year?
- Gilead Sciences's invested capital increased by 5.2% year-over-year, from $36.19B to $38.06B.
- What is the long-term trend for Gilead Sciences's invested capital?
- Over 5 years (2020 to 2025), Gilead Sciences's invested capital has grown at a -1.7% compound annual growth rate (CAGR), from $44.32B to $40.68B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Gilead Sciences's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude